Clinical Transplantation

1.8(top 50%)

impact factor

5.3K(top 5%)

papers

93.7K(top 5%)

citations

89(top 5%)

h-index

1.8(top 50%)

impact factor

6.2K

all documents

98.4K

doc citations

128(top 10%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	Low-dose dopamine after kidney transplantation: assessment by Doppler ultrasound	Clinical Transplantation	1999	533
2	Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004	Clinical Transplantation	2005	500
3	Cytomegalovirus in solid organ transplant recipients—Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice	Clinical Transplantation	2019	418
4	Infectious complications after kidney transplantation: current epidemiology and associated risk factors	Clinical Transplantation	2006	341
5	Vaccination of solid organ transplant candidates and recipients: Guidelines from the American society of transplantation infectious diseases community of practice	Clinical Transplantation	2019	307
6	Two-year incidence of malignancy in sirolimus-treated renal transplant recipients: results from five multicenter studies*	Clinical Transplantation	2004	293
7	BK polyomavirus in solid organ transplantation—Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice	Clinical Transplantation	2019	257
8	Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF)	Clinical Transplantation	1996	248
9	Cytomegalovirus in transplantation ? challenging the status quo	Clinical Transplantation	2007	245
10	Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management	Clinical Transplantation	2003	234
11	Guidelines for the treatment and management of new-onset diabetes after transplantation1.	Clinical Transplantation	2005	228
12	Urinary tract infections after renal transplantation: a retrospective review at two US transplant centers	Clinical Transplantation	2005	218
13	Management of biliary tract complications after orthotopic liver transplantation	Clinical Transplantation	2004	209
14	Post‐transplant lymphoproliferative disorders, Epstein‐Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice	Clinical Transplantation	2019	206
15	Therapeutic drug monitoring of sirolimus: correlations with efficacy and toxicity	Clinical Transplantation	2000	205
16	Central nervous system complications in liver transplant recipients - incidence, timing, and long-term follow-up	Clinical Transplantation	2000	192
17	The impact of mycophenolate mofetil dosing patterns on clinical outcome after renal transplantation	Clinical Transplantation	2003	185
18	Gastroesophageal reflux disease in lung transplant recipients	Clinical Transplantation	2003	183
19	Delayed graft function: risk factors and the relative effects of early function and acute rejection on long-term survival in cadaveric renal transplantation	Clinical Transplantation	1999	182
20	Venous complications after orthotopic liver transplantation	Clinical Transplantation	2000	173
21	Influence of diabetes mellitus on patient and graft survival in recipients of kidney transplantation	Clinical Transplantation	2001	166
22	Invasive Aspergillosis in solid‐organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice	Clinical Transplantation	2019	160
23	Pneumocystis jiroveci in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice	Clinical Transplantation	2019	159
24	Emergence of drug‐resistant cytomegalovirus in the era of valganciclovir prophylaxis: therapeutic implications and outcomes	Clinical Transplantation	2008	158
25	Impact of clinical pharmacy services on renal transplant patients’ compliance with immunosuppressive medications	Clinical Transplantation	2001	157
26	Pharmacokinetics of mycophenolic acid, tacrolimus and sirolimus after gastric bypass surgery in end‐stage renal disease and transplant patients: a pilot study	Clinical Transplantation	2008	157
27	Pulsatile machine perfusion vs. cold storage of kidneys for transplantation: a rapid and systematic review	Clinical Transplantation	2003	149
28	Wound complications following kidney and liver transplantation	Clinical Transplantation	2006	149
29	Long-term outcome of liver transplantation for autoimmune hepatitis	Clinical Transplantation	2004	140
30	Risk factors for slow graft function after kidney transplants: a multivariate analysis	Clinical Transplantation	2002	136
31	Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity	Clinical Transplantation	2007	136
32	Post-liver transplant acute renal failure: factors predicting development of end-stage renal disease*	Clinical Transplantation	2004	134
33	RNA respiratory viral infections in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice	Clinical Transplantation	2019	134
34	Urinary tract infections in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice	Clinical Transplantation	2019	131
35	Risk factors for acute renal failure requiring dialysis after liver transplantation	Clinical Transplantation	1998	129
36	Mycophenolate mofetil increases cytomegalovirus invasive organ disease in renal transplant patients	Clinical Transplantation	2000	128
37	Correlates of noncompliance among renal transplant recipients	Clinical Transplantation	1994	126
38	Increased early morbidity and mortality with acceptable long-term function in severely obese patients undergoing liver transplantation	Clinical Transplantation	1999	125
39	Health related quality of life (HRQOL) of kidney transplanted patients: variables that influence it	Clinical Transplantation	2000	125
40	Effect of macrovescicular steatosis and other donor and recipient characteristics on the outcome of liver transplantation	Clinical Transplantation	2001	124
41	Extended criteria for organ acceptance. Strategies for achieving organ safety and for increasing organ pool	Clinical Transplantation	2003	124
42	Impact of rituximab therapy for treatment of acute humoral rejection	Clinical Transplantation	2009	124
43	CMV‐hyperimmune globulin for preventing cytomegalovirus infection and disease in solid organ transplant recipients: a meta‐analysis	Clinical Transplantation	2008	122
44	Significance of the donor age effect on kidney transplants	Clinical Transplantation	1997	122
45	Expanding the donor pool: use of marginal donors for solid organ transplantation	Clinical Transplantation	1996	120
46	Two-hour cyclosporine level determination is the appropriate tool to monitor Neoral therapy	Clinical Transplantation	1998	120
47	Enteric-coated mycophenolate sodium delivers bioequivalent MPA exposure compared with mycophenolate mofetil	Clinical Transplantation	2005	119
48	Kidney transplantation from donation after cardiac death donors: lack of impact of delayed graft function on post‐transplant outcomes	Clinical Transplantation	2011	119
49	Correlates of support for organ donation among three ethnic groups	Clinical Transplantation	1999	118
50	Risk factors for early primary graft dysfunction after lung transplantation: a registry study	Clinical Transplantation	2009	116

Scientometrics

Overviews

Citing Bodies

Clinical Transplantation

Top Articles